Medicare Enrolled
Dr. Shahzad Manawar, M.D.
Pulmonary Disease · Bay City, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Manawar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manawar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Manawar
Dr. Shahzad Manawar is a pulmonary disease specialist in Bay City, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Manawar performed 1,191 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Manawar received a total of $91,875 from 45 pharmaceutical and/or device companies across 919 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Manawar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in MI
$91,875 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,191
Medicare services
Top 31% in MI for pulmonary disease
Not available
Unique patients (not deduplicated)
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
337 | $61 | $183 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
144 | $60 | $136 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
138 | $133 | $343 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
104 | $85 | $190 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
94 | $92 | $252 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
92 | $8 | $36 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
91 | $10 | $41 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
65 | $8 | $33 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
35 | $7 | $32 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $103 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $46 | $99 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
23 | $75 | $133 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $125 | $249 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$91,875
Total received (2018-2024)
Avg $13,125/year across 7 years
Top 3% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
919
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,940
2023
$12,580
2022
$24,515
2021
$32,745
2020
$8,151
2019
$3,501
2018
$2,443
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$6,995
GlaxoSmithKline, LLC.
$333
Regeneron Healthcare Solutions, Inc.
$95
Grifols USA, LLC
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
GENZYME CORPORATION
$69
Vifor Pharma, Inc.
$62
Mylan Specialty L.P.
$43
Tactile Systems Technology Inc
$25
Amgen Inc.
$25
Actelion Pharmaceuticals US, Inc.
$23
Pulmonx Corporation
$22
Philips North America LLC
$19
Mallinckrodt Hospital Products Inc.
$19
Resmed Corp
$19
Baxter Healthcare
$14
Top 3 companies account for 93.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$78,569
GlaxoSmithKline, LLC.
$3,034
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,272
GENZYME CORPORATION
$1,169
Regeneron Healthcare Solutions, Inc.
$842
Grifols USA, LLC
$807
Mylan Specialty L.P.
$626
Insmed, Inc.
$362
PFIZER INC.
$344
Genentech USA, Inc.
$338
Philips Electronics North America Corporation
$321
Actelion Pharmaceuticals US, Inc.
$292
Teva Pharmaceuticals USA, Inc.
$280
Mallinckrodt LLC
$212
United Therapeutics Corporation
$183
Takeda Pharmaceuticals U.S.A., Inc.
$182
Novartis Pharmaceuticals Corporation
$162
Mallinckrodt Enterprises LLC
$160
Sunovion Pharmaceuticals Inc.
$159
Circassia Pharmaceuticals Inc
$156
Mallinckrodt Hospital Products Inc.
$140
Baxter Healthcare
$139
JAZZ PHARMACEUTICALS INC.
$139
Electromed, Inc.
$123
Seagen Inc.
$115
PORTOLA PHARMACEUTICALS, INC.
$107
Pulmonx Corporation
$102
Vifor Pharma, Inc.
$62
Advanced Respiratory, Inc
$52
KARL STORZ Endoscopy-America
$46
SANOFI-AVENTIS U.S. LLC
$41
Inogen, Inc.
$40
Shire North American Group Inc
$38
Amgen Inc.
$37
Merck Sharp & Dohme Corporation
$34
Tactile Systems Technology Inc
$25
La Jolla Pharmaceutical Company
$24
ZOLL Respicardia, Inc.
$22
Philips North America LLC
$19
Inspire Medical Systems, Inc.
$19
Jazz Pharmaceuticals Inc.
$19
Resmed Corp
$19
Paratek Pharmaceuticals, Inc.
$17
Allergan Inc.
$13
Veran Medical Technologies, Inc.
$11
Top 3 companies account for 91.3% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · 7 FLAT PANEL MONITOR ONLY F/C-MAC · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · Corlanor · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · HDMI · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN · INSPIRE · InogenOne · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OFIRMEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · XOLAIR · XYREM · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · Zemaira · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
11
County median income
$60,523
Nearest hospital to ZIP centroid (approximate)
MCLAREN BAY REGION
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Manawar is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Manawar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Manawar performed 337 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Manawar receive payments from pharmaceutical companies?
Yes. Dr. Manawar received a total of $91,875 from 45 companies across 919 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manawar's costs compare to other pulmonary diseases in Bay City?
Dr. Manawar's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manawar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bay City
Browse pulmonary diseases in Bay City ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology